This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Tambocor (Flecainide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (8)
Death (4)
Life Threatening Events (1)
Reports by Reaction Type
Product Substitution Issue (2),
Sudden Death (2),
Death (2),
Nausea (2),
Weight Decreased (1),
Hepatic Function Abnormal (1),
Hallucination, Auditory (1),
Visual Acuity Reduced (1),
Fall (1),
Abdominal Pain Upper (1),
Face Oedema (1),
Oedema Peripheral (1)
Possible Tambocor side effects in 64 year old male
Reported by a consumer/non-health professional from United States on 2012-06-25
Patient: 64 year old male, weighing 190.0 kg (418.0 pounds)
Reactions: Product Quality Issue, Product Substitution Issue, Chest Discomfort, Blood Pressure Systolic Increased
Drug(s) suspected as cause:
Tambocor
Dosage: 100 mg;tid;
Indication: Atrial Fibrillation
Start date: 2012-05-30
Tambocor
Dosage: 100 mg;tid;
Indication: Atrial Fibrillation
Start date: 2000-01-01
End date: 2010-03-01
Flecainide Acetate
Dosage: 100 mg;tid;
Indication: Atrial Fibrillation
Start date: 2010-03-01
Other drugs received by patient: Veiva-Prostate Supplement; Whey Protein
Possible Tambocor side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-22
Patient: female, weighing 90.7 kg (199.6 pounds)
Reactions: Product Substitution Issue, Nausea, Abdominal Pain Upper
Drug(s) suspected as cause:
Tambocor
Possible Tambocor side effects in 81 year old female
Reported by a pharmacist from Japan on 2012-02-10
Patient: 81 year old female, weighing 40.0 kg (88.0 pounds)
Reactions: Weight Decreased, Hallucination, Auditory, Visual Acuity Reduced, Fall, Face Oedema, Oedema Peripheral, Dizziness, Neuroleptic Malignant Syndrome, Hallucination, Persecutory Delusion, Vomiting, Nausea, Hypochloraemia, Hyponatraemia, Head Banging, Pancreatitis, Pollakiuria, Corneal Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Galantamine Hydrobromide
Administration route: Oral
Start date: 2011-05-13
End date: 2011-05-22
Rabeprazole Sodium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-09-08
Tambocor
Indication: Product Used FOR Unknown Indication
End date: 2011-09-08
Symmetrel
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-09-08
Galantamine Hydrobromide
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-05-23
End date: 2011-09-08
Lorazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ketas
Indication: Product Used FOR Unknown Indication
End date: 2011-09-08
Norvasc
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-09-08
Diart
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-31
End date: 2011-09-06
Diart
Administration route: Oral
Start date: 2011-05-23
End date: 2011-05-30
Tolterodine Tartrate
Administration route: Oral
Indication: Pollakiuria
Start date: 2011-08-09
End date: 2011-09-08
Shimbu-TO (Chinese Herbal Medicine)
Indication: Pollakiuria
Start date: 2011-08-09
End date: 2011-09-08
Possible Tambocor side effects in 45 year old male
Reported by a physician from Netherlands on 2012-01-30
Patient: 45 year old male, weighing 88.0 kg (193.6 pounds)
Reactions: Hepatic Function Abnormal, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Metoprolol Succinate
Administration route: Oral
Indication: Arrhythmia
Start date: 2005-06-15
End date: 2005-06-15
Tambocor
Indication: Arrhythmia
Start date: 2005-06-15
End date: 2005-06-15
Possible Tambocor side effects in female
Reported by a physician from Japan on 2011-12-20
Patient: female, weighing 47.3 kg (104.1 pounds)
Reactions: Sudden Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Tambocor
Dosage: 100 mg
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2011-08-10
Tambocor
Indication: Hypertrophic Cardiomyopathy
Pradaxa
Dosage: 300 mg
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Start date: 2011-08-10
Pradaxa
Dosage: 220 mg
Administration route: Oral
Start date: 2011-09-07
End date: 2011-11-27
Tambocor
Indication: non-Obstructive Cardiomyopathy
Other drugs received by patient: Digoxin; Digoxin; Digoxin; Verapamil HCL
Possible Tambocor side effects in female
Reported by a physician from Japan on 2011-12-13
Patient: female, weighing 47.3 kg (104.1 pounds)
Reactions: Sudden Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Pradaxa
Dosage: 220 mg
Administration route: Oral
Start date: 2011-09-07
Pradaxa
Dosage: 300 mg
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Start date: 2011-08-10
Tambocor
Dosage: 100 mg
Administration route: Oral
Indication: Hypertrophic Cardiomyopathy
Start date: 2011-08-10
Tambocor
Indication: Atrial Fibrillation
Other drugs received by patient: Digoxin; Verapamil HCL; Digoxin
Possible Tambocor side effects in female
Reported by a physician from Japan on 2011-12-08
Patient: female, weighing 47.3 kg (104.1 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Tambocor
Indication: Atrial Fibrillation
Pradaxa
Dosage: 220 mg
Administration route: Oral
Start date: 2011-10-17
Pradaxa
Dosage: 300 mg
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Start date: 2011-08-10
End date: 2011-11-27
Tambocor
Dosage: 100 mg
Administration route: Oral
Indication: Hypertrophic Cardiomyopathy
Start date: 2011-08-10
Other drugs received by patient: Verapamil HCL; Digoxin; Digoxin
Possible Tambocor side effects in 60 year old female
Reported by a physician from Japan on 2011-11-30
Patient: 60 year old female, weighing 47.9 kg (105.4 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Pradaxa
Dosage: 300 mg
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Start date: 2011-08-10
End date: 2011-10-16
Pradaxa
Dosage: 220 mg
Administration route: Oral
Start date: 2011-10-17
Tambocor
Dosage: 100 mg
Administration route: Oral
Indication: Hypertrophic Cardiomyopathy
Other drugs received by patient: Digoxin; Verapamil HCL
|
